Category Archives: Genetics

Illuminating Dark Matter in Human DNA Unprecedented Atlas of the Book of Life – SciTechDaily

In an unprecedented atlas, researchers begin to map how genes are turned on or off in different cells, a step toward better understanding the connections between genetics and disease.

Researchers at University of California San Diego have produced a single-cell chromatin atlas for the human genome. Chromatin is a complex of DNA and protein found in eukaryotic cells; regions of chromatin at key gene regulatory elements appear in open configurations within certain cell nuclei. Precisely delineating these accessible chromatin regions in cells of different human tissue types would be a major step toward understanding the role of gene regulatory elements (non-coding DNA) in human health or disease.

The findings are published online in the November 12, 2021, issue of Cell.

For scientists, the human genome, popularly called the book of life, is mostly unwritten. Or at least unread. While science has famously put an (approximate) number to all of the protein-coding genes required to build a human being, approximately 20,000+, that estimation does not really begin to explain how exactly the construction process works or, in the case of disease, it might go awry.

The human genome was sequenced 20 years ago, but interpreting the meaning of this book of life continues to be challenging, said Bing Ren, PhD, director of the Center for Epigenomics, professor of cellular and molecular medicine at UC San Diego School of Medicine and a member of the Ludwig Institute for Cancer Research at UC San Diego.

A major reason is that the majority of the human DNA sequence, more than 98 percent, is non-protein-coding, and we do not yet have a genetic code book to unlock the information embedded in these sequences.

Put another way, its a bit like knowing chapter titles but with the rest of the pages still blank.

Efforts to fill in the blanks are broadly captured in an ongoing international effort called the Encyclopedia of DNA Elements (ENCODE), and include the work of Ren and colleagues. In particular, they have investigated the role and function of chromatin, a complex of DNA and proteins that form chromosomes within the nuclei of eukaryotic cells.

DNA carries the cells genetic instructions. The major proteins in chromatin, called histones, help tightly package the DNA in a compact form that fits within the cell nucleus. (There are roughly six feet of DNA tucked into each cell nucleus and approximately 10 billion miles in each human body.) Changes in how chromatin bundles up DNA are associated with DNA replication and gene expression.

After working with mice, Ren and collaborators turned their attention to a single-cell atlas of chromatin in the human genome.

They applied assays to more than 600,000 human cells sampled from 30 adult human tissue types from multiple donors, then integrated that information with similar data from 15 fetal tissue types to reveal the status of chromatin at approximately 1.2 million candidate cis-regulatory elements in 222 distinct cell types.

One of the initial challenges was identifying the best experimental conditions for such a diverse set of sample types, particularly given each tissues unique makeup and sensitivity to homogenization, said study co-author Sebastian Preissl, PhD, associate director for Single Cell Genomics at UC San Diego Center for Epigenomics, a collaborative research center that carried out the assays.

Cis-regulatory elements are regions of non-coding DNA that regulate transcription (copying a segment of DNA into RNA) of neighboring genes. Transcription is the essential process that converts genetic information into action.

Studies in the last decade have established that sequence variations in non-coding DNA are a key driver in multi-genic traits and diseases in human populations, such as diabetes, Alzheimers disease and autoimmune diseases, said study co-author Kyle J. Gaulton, PhD, assistant professor in the Department of Pediatrics at UC San Diego School of Medicine.

A new paradigm that helps explain how these noncoding variants contribute to diseases posits that these sequence alterations disrupt function of transcriptional regulatory elements and lead to dysregulation of gene expression in disease-relevant cell types, such as neurons, immune cells or epithelial cells, said co-first author Kai Zhang, PhD, a postdoctoral fellow in the Department of Cellular and Molecular Medicine. A major barrier to unlocking the function of noncoding risk variants, however, is the lack of cell-type-specific maps of transcriptional regulatory elements in the human genome.

Ren said the new findings identify disease-trait-relevant cell types for 240 multi-genic traits and diseases, and annotate the risk of noncoding variants.

We believe that this resource will greatly facilitate the study of mechanism across a broad spectrum of human diseases for many years to come.

Preissl said the chromatin atlas will also allow the scientific community to unravel tissue environment-specific differences of cell types that reside in multiple tissues, such as fibroblasts, immune cells or endothelial cells.

Reference: A single-cell atlas of chromatin accessibility in the human genome by Kai Zhang, James D. Hocker, Michael Miller, Xiaomeng Hou, Joshua Chiou, Olivier B. Poirion, Yunjiang Qiu, Yang E. Li, Kyle J. Gaulton, Allen Wang, Sebastian Preissl and Bing Ren, 12 November 2021, Cell.DOI: 10.1016/j.cell.2021.10.024

Co-authors include: James D. Hocker and Yang E. Li, Ludwig Institute for Cancer Research and UC San Diego; Michael Miller, Hiaomeng Hou, Joshua Chiou, Olivier B. Poirion and Allen Wang, all at UC San Diego; and Yunjiang Qiu, Ludwig Institute for Cancer Research, La Jolla.

Funding for this research came, in part, from the Ludwig Institute for Cancer Research, the National Human Genome Research Institute (GRANT 3U54HG006997-04S2), Foundation for the National Institutes of Health (AMP T2D RFP14), the Ruth L. Kirschstein Institutional National Science Research Award from the National Institute of General Medical Sciences (T32 GM008666).

Original post:
Illuminating Dark Matter in Human DNA Unprecedented Atlas of the Book of Life - SciTechDaily

Quinton Eriya Has The Genetics To Be A Future Mr. Olympia Threat – Fitness Volt

Canadian bodybuilder Quinton Eriya is set to return for his first bodybuilding contest in more than a year. Ahead of this event, he is looking like he has the potential to be a future star in the sport.

Eriya is just about three years into his bodybuilding career, having just three competitions under his belt so far, with his highest placing being 5th at the 2019 Toronto Pro. However he has a physique that represents what some have called the best genetics the sport has ever seen.

Whether that is true or not is up to interpretation, but one thing that is clear is that he is extremely aesthetic, and has been working to add mass to his impressive frame. He is set to return to action this weekend, for the first time in 2021, at the Romania Muscle Fest Pro, and the updates that he has been posting to his Instagram paint a picture of a severely improved physique.

One of the biggest takeaways from the 2021 Mr. Olympia, was the fact that the new generation of bodybuilders is beginning to make itself known. By all indications, Quinton Eriya is going to be one of the more impressive members of that group.

With competitors like Nick Walker and Hunter Labrada breaking through the top five at the Olympia, there seems to be a shift in the works. Now it seems that the judges are looking for a mix between the mass monsters like Big Ramy and more aesthetic physiques, which is something that Quinton represents well.

To be clear, being huge is still a relevant factor when it comes to judging, and truthfully Eriya still has some filling out to do if he wants to compete with the best in the world. However he has been making serious strides toward that, and if he can keep up the good work, there is little denying that he could be a future Olympia contender in no time.

As much as he seems to have future contender written all over him, the main objective now is for Quinton Eriya to take on the roster at the 2021 Romania Muscle Fest Pro, this weekend. If he is able to get a win or at least a solid placing, at this event, it will be a step in the right direction for this future star.

Link:
Quinton Eriya Has The Genetics To Be A Future Mr. Olympia Threat - Fitness Volt

AncestryDNA vs. 23andMe: Which DNA Kit Delivers the Best Genetic Information? – PCMag.com

DNA kits are useful, popular ways for discovering your roots, as well as identifying potential health conditions. AncestryDNA and 23andMe are the most well-known consumer DNA services, and they cost roughly the same amount of money. So, which DNA kit should you pick to learn more about your family history and genetics? We pit the DNA giants against each other to help you make an informed decision.

OnceAncestryprocesses your DNA sample, your dashboard displays an interactive map of your ethnicity estimate, possible DNA matches, and a map of where your ancestors lived. If you cancel your account, you can download your raw DNA report and take it with you.

Ancestry continually updates your results as the company collects more reference samples and builds better tools. My profile was last updated in September 2021. Subscribers can access an array of historical records, including Census data; create family trees; and contact other Ancestry members.

The company offers three subscription options: AncestryDNA (the original version), AncestryDNA + World Explorer Membership, and AncestryDNA Traits + All Access Membership. The World Explorer Membership opens up access to international records, and the All Access Membership includes access to Fold3 and Newspapers.com. Fold3 has over half a million military records and millions of nonmilitary. A membership to Newspapers.com comes with more than 2 billion articles that go back to the 1700s.

The third-tier plan includes AncestryDNA Traits, which tests for more than 30 traits. These tests reveal many traits, including eye color, vitamin levels, and muscle fatigue. You can view how AncestryDNA determined your results, and learn which factors besides genetics affect those traits, such as diet.

23andMereports cover a few categories: Ancestry Composition, DNA Relatives List, Neanderthal Ancestry, and Maternal and Paternal haplogroups. You unearth more detail by interacting with the map on the ancestry composition page, including the exact heritage percentages. You can also see the last time when that information was updated (our data was refreshed in June 2021).

Based on your mitochondrial (maternal) DNA, the maternal haplogroup section shows which haplogroup you belong to, as well as subgroups. People in the same haplogroup have a common ancestor. For example, the haplogroup T2b shares an ancestor who lived 10,000 years ago; most people in this haplogroup live in Europe. The Y chromosome determines paternal haplogroups.

If you're genetically male (as in, you have an X chromosome and a Y chromosome), you can view both your maternal and paternal lines. People with two X chromosomes can't access this data unless their father or brother submits their DNA.

23andMe offers three options: Ancestry + Traits Service; Health + Ancestry Service; and 23andMe+ membership, including the Health + Ancestry kit. The membership includes more in-depth health information, advanced DNA Relative filters, and access to more than three times the DNA Relatives.

Winner:23andMe

AncestryDNA briefly offered DNA-based health testing starting in 2019, but discontinued the service in winter 2020 to focus on its core products. Members who used this product during its brief lifespan had a chance to download their results in 2020, but they're no longer available in their profiles.

23andMe's Health and Traits reports are available in several categories, such as Health Predisposition, Carrier Status, and Wellness. The company tests for many conditions, including Celiac disease, macular degeneration, and Type-2 diabetes. As mentioned earlier, it also tests for traits like your alcohol flush reaction, muscle composition, and even asparagus odor detection (very likely in our case). The company continues to add new reports.

Even if you've opted out of health testing, you can optionally fill out 23andMe's health questionnaires to help with company research. You can also choose to save your saliva samples at 23andMe's labs for future testing. Otherwise, 23andMe will destroy your sample once it's processed (Ancestry will destroy your sample on request).

Winner:23andMe

AncestryDNA searches its database for matches using the service's DNA Matches feature. Only your username, possible relationship, and genetic ethnicity are visible to other members. AncestryDNA continues to search for matches as its database grows.

Ancestry started as family tree software, and it incorporates your AncestryDNA results into your existing family trees. Aside from that, AncestryDNA has a feature called ThruLines, which uses public Ancestry family trees and your private trees to show common ancestors you share with your matches. It also displays potential ancestors from your grandparents to multiples of great grandparents. If you mouse over a probable ancestor, AncestryDNA shows you how many DNA matches are in its system. You can view as much information about your matches as the matches allow, which can be as little as their relationship to you.

Like AncestryDNA, 23andMe looks for DNA matches among its other members, but only if you opt-in to its DNA Relatives program. You'll get email alerts about possible matches and their relationship with you. You can turn on open sharing to make specific details available for other members, such as your full name. If you leave this off, other users must send you a share request. Depending on profile settings, you can either send a message or an introduction.

Winner:Ancestry

AncestryDNA and 23andMe are both excellent DNA testing services, but they have different focuses. The former is a good choice if youre building a family tree, but the latter has robust health-testing capabilities, and rich reports on maternal/paternal lines and Neanderthal ancestry.In short, 23andMe is the DNA kit you should buy if you're looking for a wide view of your genetics.

Overall Winner:23andMe

Note that it's not just your family's human members whose ancestry might interest you.The best dog DNA test kitscan help you tell a Maltese from a mutt, and we've reviewed the top choices in that category.

Sign up for Lab Report to get the latest reviews and top product advice delivered right to your inbox.

This newsletter may contain advertising, deals, or affiliate links. Subscribing to a newsletter indicates your consent to our Terms of Use and Privacy Policy. You may unsubscribe from the newsletters at any time.

Original post:
AncestryDNA vs. 23andMe: Which DNA Kit Delivers the Best Genetic Information? - PCMag.com

Sex-specific differences in aging and Alzheimer’s disease may be tied to genetics – National Institute on Aging

When it comes to cognitive aging and Alzheimers disease, the differences between men and women may be related to genetics. According to an NIA-supported study published in JAMA Neurology, August 2021, genes contained in the X chromosome may hold the key to differences between men and women in aging and Alzheimers-related cognitive decline.

Cognitive changes can affect memory, attention, and executive functions such as planning and self-control. These changes can occur as a result of the natural process of aging or dementia such as Alzheimers. Sometimes, cognitive changes are accompanied by changes in the brain such as the formation of neurofibrillary tangles, a hallmark characteristic of the brain tissue associated with Alzheimers. The tangles involve the twisting of tau protein threads of the nerve cells in the brain tissue. The rate and degree of cognitive decline, as well as the extent of neurofibrillary tangles, differ between men and women.

In this study, scientists led by a team at the University of California, San Francisco, analyzed genetic and clinical data from a joint cohort consisting of two long-term studies: the Religious Orders Study and the Rush Memory and Aging Project. The scientists gathered genetic data from the brain tissue of 508 autopsied individuals via RNA sequencing, a technique used to measure how many copies of specific genes are present in a humans cells at a given time.

The scientists also gathered data about participants cognitive function over several years to assess changes in cognition, including memory and attention. Participants did not have dementia at the time of their enrollment in the studies and were monitored periodically until their death. Using genetic and clinical data, the scientists examined associations of cognitive changes and levels of neurofibrillary tangles with genes on the X chromosome.

The X chromosome is one of the two sex chromosomes in humans (the Y chromosome is the other). Women have two X chromosomes, and men have one X and one Y. Unlike the Y chromosome, which contains just 50 to 60 genes, the X chromosome contains hundreds of genes, many of which are related to brain function. However, not much is known about how the expression of X chromosome-linked genes affects brain changes in aging and Alzheimers. Gene expression is the process by which the instructions in our DNA are converted into a functional product, such as a protein.

The scientists found that the expression levels of 19 genes on the X chromosome were linked to changes in cognition and quantity of neurofibrillary tangles. In women, this increased expression was associated with slower cognitive decline. The expression of these genes was not increased in men. This may suggest that specific genes on the X chromosome help protect women from cognitive decline in aging and Alzheimers.

In contrast, the expression of three X chromosome genes associated with neurofibrillary tangles was increased in men. This may suggest that men could be more at risk of developing Alzheimers-related pathological changes than women.

Because this study used a sample population that was 98% white, future studies must be conducted on a more diverse sample. Nonetheless, the expression of X chromosome genes may uncover some of the genetic differences in cognitive aging and Alzheimers between men and women. Research to further examine the role of X chromosome genes in aging and Alzheimers could help advance personalized treatment options for both men and women.

This research was funded in part by NIA grants RF1AG068325, P30AG10161, R01AG15819, R01AG17917, U01AG61356, U01AG46152, R01AG36836, R01AG060393, and R01AG062588.

These activities relate to NIHs AD+ADRD Research Implementation Milestone 2.D, Create programs in basic, translational and clinical research aimed at comprehensive understanding of the impact of sex differences on the trajectories of brain aging and disease, phenotypes of AD and ADRD risk and responsiveness to treatment.

Reference: Davis EJ, et al. Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer Disease. JAMA Neurology. 2021 Aug 23;e212806. doi: 10.1001/jamaneurol.2021.2806.

Read more:
Sex-specific differences in aging and Alzheimer's disease may be tied to genetics - National Institute on Aging

Genetic Research Reveals New Clues for the Shared Origins of Irritable Bowel Syndrome and Mental Health Disorders – SciTechDaily

Irritable bowel syndrome. Credit: Scientific Animations

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.

IBS is a common condition world-wide, affecting around 1 in 10 people and causing a wide range of symptoms including abdominal pain, bloating, and bowel dysfunction that can significantly affect peoples lives. Diagnosis is usually made after considering other possible conditions (such as Crohns disease or bowel cancer), with clinical tests coming back normal. The condition often runs in families and is also more common among people who are prone to anxiety. The causes of IBS are not well understood, but an international team of researchers has now identified several genes that provide clues into the origins of IBS.

Although IBS occurs more frequently in those who are prone to anxiety, we dont believe that one causes the other our study shows these conditions have shared genetic origins. Miles Parkes

The research team, including more than 40 institutions and coordinated by scientists in UK and Spain, looked at genetic data from 40,548 people who suffer from IBS from the UK Biobank and 12,852 from the Bellygenes initiative (a world-wide study aiming to identify genes linked to IBS) and compared them to 433,201 people without IBS (controls), focusing on individuals of European ancestry. The findings were repeated with de-identified data from the genomics company 23andMe Inc., provided by customers who have consented to research, by comparing 205,252 people with IBS to 1,384,055 controls.

The results showed that overall, heritability of IBS (how much your genes influence the likelihood of developing a particular condition) is quite low, indicating the importance of environmental factors such as diet, stress and patterns of behavior that may also be shared in the family environment.

However, 6 genetic differences (influencing the genes NCAM1, CADM2, PHF2/FAM120A, DOCK9, CKAP2/TPTE2P3 and BAG6) were more common in people with IBS than in controls. As IBS symptoms affect the gut and bowel, it would be expected that genes associated with increased risk of IBS would be expressed there but this is not what the researchers found. Instead, most of the altered genes appear to have more clear-cut roles in the brain and possibly the nerves which supply the gut, rather than the gut itself.

Researchers also looked for overlap between susceptibility to IBS and other physical and mental health conditions. They found that the same genetic make-up that puts people at increased risk of IBS also increases the risk for common mood and anxiety disorders such as anxiety, depression, and neuroticism, as well as insomnia. However, the researchers stress that this doesnt mean that anxiety causes IBS symptoms or vice versa.

Study co-senior investigator and consultant gastroenterologist Professor Miles Parkes from the University of Cambridge explained: IBS is a common problem, and its symptoms are real and debilitating. Although IBS occurs more frequently in those who are prone to anxiety, we dont believe that one causes the other our study shows these conditions have shared genetic origins, with the affected genes possibly leading to physical changes in brain or nerve cells that in turn cause symptoms in the brain and symptoms in the gut.

The study also found that people with both IBS and anxiety were more likely to have been treated frequently with antibiotics during childhood. The study authors hypothesize that repeated use of antibiotics during childhood might increase the risk of IBS (and perhaps anxiety) by altering the normal gut flora (healthy bacteria that normally live in the gut) which in turn influence nerve cell development and mood.

Current treatments for IBS vary widely and include dietary changes, prescription medications targeting the gut or brain, or behavioral interventions. Lead author Chris Eijsbouts from the University of Oxford suggests that discovering genes that contribute to IBS may aid in the development of new treatments in the long term. He said: Even genetic changes that have only subtle effects on IBS can provide clues about pathways to target therapeutically. Unlike the individual genetic changes themselves, drugs targeting the pathways they tell us about may have a considerable impact on the condition, as we know from other disease areas.

Co-senior investigator Dr Luke Jostins from the University Oxford commented: We anticipate that future research will build on our discoveries, both by investigating the target genes identified and exploring the shared genetic risk across conditions to improve understanding of the disordered brain-gut interactions which characterize IBS.

IBS represents a remarkable challenge for genetic studies. These initial findings have been long awaited, and finally tell us this type of research is worth the struggle, added Ikerbasque Professor Mauro DAmato from CIC bioGUNE, co-senior investigator and coordinator of the Bellygenes initiative.

Reference: Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders by Chris Eijsbouts, Tenghao Zheng, Nicholas A. Kennedy, Ferdinando Bonfiglio, Carl A. Anderson, Loukas Moutsianas, Joanne Holliday, Jingchunzi Shi, Suyash Shringarpure, 23andMe Research Team, Alexandru-Ioan Voda, The Bellygenes Initiative, Gianrico Farrugia, Andre Franke, Matthias Hbenthal, Gonalo Abecasis, Matthew Zawistowski, Anne Heidi Skogholt, Eivind Ness-Jensen, Kristian Hveem, Tnu Esko, Maris Teder-Laving, Alexandra Zhernakova, Michael Camilleri, Guy Boeckxstaens, Peter J. Whorwell, Robin Spiller, Gil McVean, Mauro DAmato, Luke Jostins and Miles Parkes, 5 November 2021, Nature Genetics.DOI: 10.1038/s41588-021-00950-8

This research received funding and support from National Institute for Health Research (NIHR) Biomedical Research Centres in Cambridge, Oxford, Nottingham and Manchester. Further funding and support was received from the Wellcome Trust, the Li Ka Shing Foundation and the Kennedy Trust for Rheumatology Research in the UK, and the Spanish Ministry of Economy and Competitiveness (Instituto Salud Carlos III), the Health Department of the Basque Government and the Swedish Research Council (Vetenskapsradet).

Read the original:
Genetic Research Reveals New Clues for the Shared Origins of Irritable Bowel Syndrome and Mental Health Disorders - SciTechDaily

Genetics, History, and the Mystery of Jewish Resilience Mosaic – Mosaic

Why do I have to complete a CAPTCHA?

Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.

If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.

If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices.

Another way to prevent getting this page in the future is to use Privacy Pass. You may need to download version 2.0 now from the Firefox Add-ons Store.

The rest is here:
Genetics, History, and the Mystery of Jewish Resilience Mosaic - Mosaic

Scientists find genetic goldmine in driest place on Earth that may boost crop resilience – ZME Science

The Atacama Desert. Credit: Pixabay.

For years, Chilean researchers have collected plant samples from the Atacama Desert and sequenced their DNA in an effort to understand how, against all odds, theyre able to withstand one of the harshest places on Earth. In a new study, the scientists have reported a range of genes that have enabled these hardy plants to flourish with no rainwater and which, in the future, may help our food crops cope with increasingly dried climates.

The Atacama Desert in Chile stretches across a roughly 600-mile (1,000-kilometer) tract of land wedged between the coastal Cordillera de la Costa mountain range and the Andes Mountains, an unusual topography that blocks rainfall from the east and prevents the formation of clouds of rain. The annual rainfall across the Atacama is only 15 millimeters, which makes it the driest place on Earth by far. Some parts of the desert see rain only once in a couple of centuries and its extreme arid landscape has made it a film directors favorite place to shoot movies about Mars.

But even though the Atacama Desert sounds like a hell hole, there are some plants that have found a way to cope with the extreme dryness, high altitude, poor nutrient soil, and excessive radiation from the sun. These are generally small, deep-rooted, thorny plants that can reach deep underground to capture some of the moisture found there. These include the saltbush, tufted grass, buckwheat bush, black bush, tola shrubs, rice grass, ferns, little leaf horsebrush, black sage, and chrysothamnus.

For the last decade, Rodrigo Gutirrez, professor in the Department of Molecular Genetics and Microbiology at Pontificia Universidad Catlica de Chile, has collected plants from 22 different sites covering a wide range of vegetation and elevations. For each sample, Gutirrez and colleagues recorded a variety of factors, such as temperature, radiation levels, soil quality, and water content.

This characterization for each sample, along with DNA sequencing, allowed the researchers to assemble a genetic profile for 32 of the most important plant species in the Atacama. The analysis also assessed the plant-associated soil microbes based on these DNA sequencing, showing that some of the plants developed symbiotic bacteria near their roots that optimize the intake of nitrogen, a critical nutrient for plant growth that is severely lacking in this desert.

Colleagues at New York University led by Gloria Coruzzi from the Department of Biology and Center for Genomics and Systems Biology identified the specific genes that are associated with adaptations in the Atacama plants by comparing the 32 desert plants with 32 non-adapted but genetically similar sister species.

The goal was to use this evolutionary tree based on genome sequences to identify the changes in amino acid sequences encoded in the genes that support the evolution of the Atacama plant adaptation to desert conditions, said Coruzzi.

This state-of-the-art genetic analysis pinpointed 265 genes whose protein sequence may have been selected by evolutionary forces, forged by millions of years of life in the harsh Atacama desert. These include genes involved in photosynthesis that may allow the plants to cope with the high radiation, as well as those involved in the regulation of stress, salt, and metal ions, which may explain how the plants can grow in the nutrient-poor soil.

Our study of plants in the Atacama Desert is directly relevant to regions around the world that are becoming increasingly arid, with factors such as drought, extreme temperatures, and salt in water and soil posing a significant threat to global food production, said Gutirrez, who likens the findings to a genetic goldmine.

Some of the Atacama plants are related to staple crops, such as grains, legumes, and potatoes. As such, these newly identified candidate genes could be used to engineer more resilient crops and improve our food security in the face of increased desertification of the planet.

The findings appeared in the journal Proceedings of the National Academy of Sciences.

Link:
Scientists find genetic goldmine in driest place on Earth that may boost crop resilience - ZME Science

Into the woods: Genetics of rainforest tree reveal its past and possible future – EurekAlert

image:Researchers from the University of Tsukuba have found that Shorea parvifolia, a tropical rainforest tree species widely distributed through Southeast Asia, has had a recent migration to Borneo followed by a population increase. The teams analyses of the species genetic structure revealed that the Borneo populations have a high genetic diversity, indicating a recent population expansion. The studys results support the use of locally sourced seeds for planting as a tool for maintaining genetic diversity. view more

Credit: University of Tsukuba

Tsukuba, Japan For most people who go for a walk in a forest, their surroundings seem unchanging. But researchers from Japan have discovered that, on a geological time scale, one rainforest tree species has been getting up to all sorts of antics.

In a study published this month in Tree Genetics & Genomes, researchers from the University of Tsukuba have revealed that a tropical rainforest tree species underwent a recent and rapid population expansion in Borneo, showing that an understanding of a species past is important for ensuring its future.

Biodiversity loss is one of the most pressing problems of our time. Ecosystems such as tropical rainforests, which have high biodiversity and species richness, face ongoing threats from changing land use and over-exploitation by humans. To conserve the tree species living in these environments, it is important to understand their genetics and how their current genetic structures were established.

We investigated the genetics of Shorea parvifolia, a widely distributed tropical forest tree in Southeast Asia, says senior author of the study, Professor Yoshihiko Tsumura. Its genetic structure has been affected by repeated glacial and interglacial fluctuations; these genetic changes provide key knowledge for sustainable use and conservation.

S. parvifolia is important for ecosystem function and forestry in Southeast Asia. To examine its genetics, the researchers took leaf samples from trees in natural populations that covered almost the entire geographical range of S. parvifolia. The team used nuclear DNA markers and the DNA sequencing data of chloroplasts (the plant cell structures that carry out photosynthesis) to examine the genetic structure of S. parvifolia and how it was established.

The nuclear DNA analysis of the genetic structure showed a clear separation between the Borneo populations and the others, explains Professor Tsumura.

Although the genetic structure shown by the chloroplast DNA was less pronounced, further analysis showed important differences in the Borneo populations. The results indicated that S. parvifolia has had a recent population expansion in Borneo.

The high genetic diversity at particular genetic markers in the Borneo samples suggest that during the most recent glacial period, populations of this species likely migrated from the Malay Peninsula to Borneo and then underwent a major population increase, amassing considerable genetic diversity, says Professor Tsumura.

On the basis of the results of their study, the researchers have suggested that conservation units in this area be divided into three regions: the Malay Peninsula, Sumatra, and Borneo. The teams findings also highlight the benefit of using locally sourced seeds for plantings aimed at improving conservation and sustainability in tropical forests of Southeast Asia, because doing so could maintain species genetic diversity.

###

The article, Genetic structure of an important widely distributed tropical forest tree, Shorea parvifolia, in Southeast Asia, was published in Tree Genetics & Genomes at DOI: 10.1007/s11295-021-01525-8

Funding: The study was partly supported by Grant-in-Aids for Scientific Research (Nos. 24405034, 18255010) provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Global Environment Research Program (No. E-091) supported by the Ministry of Environment of Japan.

Genetic structure of an important widely distributed tropical forest tree, Shorea parvifolia, in Southeast Asia

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Go here to see the original:
Into the woods: Genetics of rainforest tree reveal its past and possible future - EurekAlert

Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting 2021 – PRNewswire

IRVINE, Calif.and TEMPLE CITY, Calif., Nov. 1, 2021 /PRNewswire/ --Helio Health("Helio"), an AI-driven healthcare company developing blood-based early cancer detection tests, and Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced its upcoming late-breaking poster presentation on the performanceof HelioLiver, a multi-analyte blood test that utilizes both cell-free DNA (cfDNA) methylation patterns and protein tumor markers for the detection of hepatocellular carcinoma (HCC), at The Liver Meeting 2021. The annual meeting is hosted by the American Association for the Study of Liver Diseases (AASLD) and will be held virtually November 12-15, 2021.

Details of the poster presentation are as follows:

Poster Title:A Multi-Analyte Blood Test for Accurate and Early Detection of Hepatocellular Carcinoma Publication Number:LP44Session Title: Late-breaking Abstract Posters Presenter: David J. Taggart, PhD, NRCC(CC) Laboratory Director and Vice President of Laboratory Operations and Regulatory Affairs, Helio Health Inc.

The full abstract can be found here. The poster presentation will be available for viewing by the attendees of The Liver Meeting throughout the entire meeting.

About Helio Health

Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company's mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio's AI-driven technology, both physicians and their patients gain powerful insights from accurate, accessible, and convenient blood tests.

Building on a robust research and development program, and with access to thousands of patient samples, the company is currently in clinical trials in the US and China with its lead liver cancer detection test. Helio's development program is focused on liver, colon, breast and lung cancer.

Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN, Guangzhou and Beijing.

About Fulgent Genetics

Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent's proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. Combining next generation sequencing with its technology platform, Fulgent performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. A cornerstone of our business is our ability to provide expansive options and flexibility for all clients' unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated lab services.

About Helio Health and Fulgent Genetics Partnership

In a strategic partnership announced in August of 2021, Helio Health and Fulgent Genetics plan to commercialize and co-brand HelioLiver, a cell-free DNA (cfDNA) methylation blood test that incorporates protein markers and demographics for the detection of hepatocellular carcinoma (HCC) or liver cancer. HelioLiver is currently undergoing clinical trials in the U.S. and China. Fulgent will be responsible for laboratory operations, supply chain operations, and marketing and sales leveraging its operational excellence and significant market reach, initially focused in the U.S. and Canada. Helio will provide intellectual property and continued support across research and development, publication development, market access and sales, as well as reimbursement operations. Fulgent and Helio will also collaborate on the development of additional liquid biopsy tests for different types of cancer in the future.

SOURCE Helio Health and Fulgent Genetics, Inc.

Go here to see the original:
Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting 2021 - PRNewswire

Moving past conflation of race and genetics | Penn Today – Penn Today

In a new viewpoint article in the Journal of the American Medical Association (JAMA) Pediatrics, two researchers from Penns School of Nursing explore the history behind, and implications of, the conflation of race and genetics using examples from the pediatric literature. They provide insight into why its a fallacy and what scientists and clinicians can do to move past the use of race as a tool for classification in laboratory and clinical research.

We need to admit that race is a social construct and conduct research accordingly. Continuing education is urgently needed for scientists and clinicians about the differences between genetics and race, says Rebecca Clark, assistant professor of nursing at the Center for Health Outcomes and Policy Research and one of the authors of the article.

In the article, the authors discuss two studies which examined racial differences in the development and treatment of neonatal abstinence syndrome (NAS), sometimes more specifically called neonatal opioid withdrawal syndrome (NOWS), among Black and white newborns. The studies reported racial differences in treatment and interpreted this as reflecting genetic differences between the study participants, instead of interpreting their findings as an example of racism appearing in the form of inequitable treatment according to race.

Read more at Penn Nursing News.

View original post here:
Moving past conflation of race and genetics | Penn Today - Penn Today